| Page 1858 | Kisaco Research
 

Nicole Hemsoth

Co-Founder and Co-Editor
The Next Platform

Nicole Hemsoth

Co-Founder and Co-Editor
The Next Platform

Nicole Hemsoth

Co-Founder and Co-Editor
The Next Platform
 

Stacey Higginbotham

Founder
Stacey on IoT

Stacey Higginbotham

Founder
Stacey on IoT

Stacey Higginbotham

Founder
Stacey on IoT
 

Stacey Higginbotham

Founder
Stacey on IoT

Stacey Higginbotham

Founder
Stacey on IoT

Stacey Higginbotham

Founder
Stacey on IoT
 

Igor Taber

Managing Director, AI and Data Infrastructure
Intel Capital

Igor Taber

Managing Director, AI and Data Infrastructure
Intel Capital

Igor Taber

Managing Director, AI and Data Infrastructure
Intel Capital
 
24-25 Oct 2018
Hong Kong 中国香港, 2018年10月24 – 25日
Animal Health Innovation Asia is a premier B2B conference showcasing emerging Animal Health and Nutrition companies, from China and across Asia-Pacific, that are activity seeking financial investment or strategic partnership conversations with large corporate firms.Our plenary sessions provide guidance on veterinary market trends and animal health industry dynamics in China & A-PAC, insight on how emerging companies are using new innovations to prevent disease and market analysis on the M&A activity across the animal health and nutrition markets in Asia.
 

Dr. Bradford McRae

Project Director
AbbVie Discovery Immunology

Brad is a Project Director in Immunology Discovery.  He has led both internal drug discovery projects and external collaborations including work on the microbiome with a focus on therapeutics for the treatment of IBD.  He leads a cross-functional group within Abbvie responsible for executing on the Discovery and Clinical strategy in Gastroenterology.  His experience in project leadership, immunology, and in vivo pharmacology ranges from the target identification phase through drug candidate selection and IND. 

Dr. Bradford McRae

Project Director
AbbVie Discovery Immunology

Dr. Bradford McRae

Project Director
AbbVie Discovery Immunology

Brad is a Project Director in Immunology Discovery.  He has led both internal drug discovery projects and external collaborations including work on the microbiome with a focus on therapeutics for the treatment of IBD.  He leads a cross-functional group within Abbvie responsible for executing on the Discovery and Clinical strategy in Gastroenterology.  His experience in project leadership, immunology, and in vivo pharmacology ranges from the target identification phase through drug candidate selection and IND. 

 

Daniel Couto

Chief Technical Officer
Vedanta Biosciences

Daniel Couto

Chief Technical Officer
Vedanta Biosciences

Daniel Couto

Chief Technical Officer
Vedanta Biosciences
 

Dr. Vincent Pedre

IFM Certified Practitioner, Medical Director, and Founder
Pedre Integrative Health, and Dr. Pedre Wellness

Dr. Vincent Pedre

IFM Certified Practitioner, Medical Director, and Founder
Pedre Integrative Health, and Dr. Pedre Wellness

Dr. Vincent Pedre

IFM Certified Practitioner, Medical Director, and Founder
Pedre Integrative Health, and Dr. Pedre Wellness
 

Amir Bein

Postdoctoral Research Fellow
Wyss Institute for Biologically Inspired Engineering, Harvard University

Amir is a senior postdoctoral fellow at Don Ingber’s lab at the Wyss Institute for Biologically Inspired Engineering at Harvard University. Amir received his PhD from the Hebrew University of Jerusalem and is a Hoffman Leadership and Responsibility Fellowship Program laureate. He is a certified dietitian with past in/out patient and private clinic experience in clinical nutrition.

Amir Bein

Postdoctoral Research Fellow
Wyss Institute for Biologically Inspired Engineering, Harvard University

Amir Bein

Postdoctoral Research Fellow
Wyss Institute for Biologically Inspired Engineering, Harvard University

Amir is a senior postdoctoral fellow at Don Ingber’s lab at the Wyss Institute for Biologically Inspired Engineering at Harvard University. Amir received his PhD from the Hebrew University of Jerusalem and is a Hoffman Leadership and Responsibility Fellowship Program laureate. He is a certified dietitian with past in/out patient and private clinic experience in clinical nutrition.

Amir has extensive research experience in intestinal physiology and pathophysiology with a focus on mechanisms of gut inflammation. His biophysical work covers the development of a label free SPR based cells biosensor and a method for cryopreservation of adherent cells.

Current work at the Ingber lab focuses on developing in-vitro models for intestinal infection and Environmental Enteric Dysfunction (EED) using Organ-On-Chip microfluidic technology that can recapitulate the multicellular architectures, tissue-tissue interfaces, chemical gradients, mechanical cues and vascular perfusion of the body.